ERC-2018-PoC
ERC-2018-PoC
Programme: H2020
160 projects · €23,921,092 total EU contribution (project-level) · 125 participating organizations · 20 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€23,921,092
Countries active
Participant organizations by country (headquarters in CORDIS).
- Italy (17)
- UK (17)
- Spain (16)
- Germany (14)
- Netherlands (13)
- France (10)
- AT (6)
- CH (6)
- FI (4)
- IL (4)
- BE (3)
- IE (3)
- PT (3)
- SE (2)
- SK (2)
- BG (1)
- CY (1)
- DK (1)
- HR (1)
- NO (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- WEIZMANN8 projects · IL
- UOXF7 projects · UK
- CNRS5 projects · FR
- TECHNION - ISRAEL INSTITUTE OF TECHNOLOGY5 projects · IL
- THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE5 projects · UK
- CNRS INNOVATION4 projects · FR
- IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE4 projects · UK
- POLIMI4 projects · IT
- IIT3 projects · IT
- IRB BARCELONA - CERCA3 projects · ES
- IBM3 projects · CH
- UNIVERSITY COLLEGE LONDON3 projects · UK
Projects
Page 14 of 16
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
tPA-Nanoconstructs for Treating Acute Ischemic Stroke: a Technical and Commercial Analysis RESOLVE · 840331 | H2020 | €150,000 | €150,000 | Details |
Bioinspired superhydrophbic wax surfaces to eliminate biofilm formation in the food industry Antiseptic-Wax · 813258 | H2020 | €150,000 | €150,000 | Details |
Translation and Commercialization of a QSOX1-inhibitory Antibody Targeting the Tumor Microenvironment in Breast Cancer CONQR · 825076 | H2020 | €149,998 | €149,998 | Details |
Automated evaluation and correction of generation bias in immune receptor repertoires PGEN · 824735 | H2020 | €149,906 | €149,906 | Details |
Development and commercialisation of a new purification system for contaminant-free radiocarbon dating ChromaChron · 812309 | H2020 | €136,238 | €136,238 | Details |
Biocatalytic Methyltransferase Cascades MetTraC · 840243 | H2020 | €149,760 | €149,760 | Details |
BIOHYBRID AND BIODEGRADABLE NANOVACCINES FOR CANCER IMMUNOTHERAPY iNANOVAC4CANCER · 825020 | H2020 | €150,000 | €150,000 | Details |
Development of antibacterial compounds that block essential transport function VitaminBlock · 812867 | H2020 | €150,000 | €150,000 | Details |
Launch Test of Natural Biocides for the Control of Insect Borne Diseases LaunTeNaBio · 842429 | H2020 | €149,685 | €134,060 | Details |
Industrial implementation of a step-change technology to measure fluorescence FLUO · 825879 | H2020 | €150,000 | €150,000 | Details |